{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Skandalou E"],"funding":["South-Eastern Norway Regional Health Authority","Oslo Diabetes Research Centre (Novo Nordisk)"],"pagination":["e70000"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12069002"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["19(3)"],"pubmed_abstract":["<h4>Purpose</h4>Diabetes mellitus (DM) is a major cause of end-stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post-transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic nephropathy (DN). This study aimed to investigate the molecular differences in PTDM by mapping the proteomes of proximal tubuli and serum in normoglycemic (NG), pre-transplant T2DM, and PTDM patients one year post-transplantation. Experimental Design Proteomic analysis was performed on microdissected proximal tubular cells and serum samples from kidney transplant recipients categorized as NG, pre-transplant T2DM, or PTDM at one year post-tran"],"journal":["Proteomics. Clinical applications"],"pubmed_title":["Proteome of Renal Tubuli and Serum Differentiate Pre-Existing Type 2 Diabetes and Post-Transplant Diabetes in Kidney Transplant Recipients."],"pmcid":["PMC12069002"],"funding_grant_id":["2016069"],"pubmed_authors":["Asberg A","Vikse BE","Skandalou E","Marti HP","Rivedal M","Halden TAS","Furriol J","Jenssen T"],"additional_accession":[]},"is_claimable":false,"name":"Proteome of Renal Tubuli and Serum Differentiate Pre-Existing Type 2 Diabetes and Post-Transplant Diabetes in Kidney Transplant Recipients.","description":"<h4>Purpose</h4>Diabetes mellitus (DM) is a major cause of end-stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post-transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic nephropathy (DN). This study aimed to investigate the molecular differences in PTDM by mapping the proteomes of proximal tubuli and serum in normoglycemic (NG), pre-transplant T2DM, and PTDM patients one year post-transplantation. Experimental Design Proteomic analysis was performed on microdissected proximal tubular cells and serum samples from kidney transplant recipients categorized as NG, pre-transplant T2DM, or PTDM at one year post-tran","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 May","modification":"2026-06-02T20:47:40.522Z","creation":"2026-04-20T03:14:28.766Z"},"accession":"S-EPMC12069002","cross_references":{"pubmed":["39989279"],"doi":["10.1002/prca.70000"]}}